ELP1 and pancreatic adenocarcinoma: The human pancreatic adenocarcinoma cell line MIA PaCa-2 was especially sensitive to Tat-ELP1-L12 treatment, and one hour application of the polypeptide under hyperthermia conditions resulted in 70-90% inhibition of cell proliferation.